| |
| |
|
| Insider
Information: |
Lloyd-Smith Malcolm |
| Relationship: |
Chief Integration Offi... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
42,337 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,787,468 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
42,337 |
|
|
| Total
Value |
$5,787,468 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cadence Pharmaceuticals Inc |
CADX |
SVP, Reg Affairs, Qual... |
2014-03-19 |
0 |
|
0 |
Premium* |
|
|
Neurocrine Biosciences Inc |
NBIX |
Chief Integration Offi... |
2023-02-08 |
42,337 |
2016-05-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CADX |
Cadence Pharmaceuticals I... |
SVP, Reg Affairs, Qual & ClinO |
• – – |
2012-09-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,332 |
|
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, Reg Affairs, Qual & Clin |
• – – |
2013-07-22 |
4 |
OE |
$3.51 |
$49,140 |
D/D |
14,000 |
16,332 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, Reg Affairs, Qual & Clin |
• – – |
2013-06-10 |
4 |
AS |
$7.44 |
$29,760 |
D/D |
(4,000) |
2,332 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, Reg Affairs, Qual & Clin |
• – – |
2013-07-22 |
4 |
AS |
$7.85 |
$109,900 |
D/D |
(14,000) |
2,332 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, Reg Affairs, Qual & Clin |
• – – |
2014-03-19 |
4 |
D |
$14.00 |
$32,648 |
D/D |
(2,332) |
0 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2016-05-31 |
4 |
OE |
$15.45 |
$139,050 |
D/D |
9,000 |
9,000 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2016-09-01 |
4 |
OE |
$15.45 |
$139,050 |
D/D |
9,000 |
9,000 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2017-05-18 |
4 |
OE |
$15.45 |
$76,941 |
D/D |
4,980 |
17,997 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2017-05-19 |
4 |
OE |
$15.45 |
$76,941 |
D/D |
4,980 |
17,997 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2018-01-02 |
4 |
OE |
$15.45 |
$279,398 |
D/D |
18,084 |
31,101 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2018-11-06 |
4 |
OE |
$15.45 |
$88,065 |
D/D |
5,700 |
21,018 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2018-11-07 |
4 |
OE |
$15.45 |
$50,985 |
D/D |
3,300 |
18,618 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2019-10-14 |
4 |
OE |
$15.45 |
$153,820 |
D/D |
9,956 |
29,569 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2020-02-10 |
4 |
OE |
$32.99 |
$1,728,147 |
D/D |
28,969 |
39,127 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2021-01-25 |
4 |
OE |
$32.99 |
$605,470 |
D/D |
17,570 |
37,960 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2021-01-26 |
4 |
OE |
$35.99 |
$39,589 |
D/D |
1,100 |
29,602 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2021-02-10 |
4 |
OE |
$35.99 |
$61,183 |
D/D |
1,700 |
33,110 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2022-08-12 |
4 |
OE |
$35.99 |
$774,973 |
D/D |
21,533 |
40,421 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2022-08-15 |
4 |
OE |
$35.99 |
$369,663 |
D/D |
8,043 |
26,931 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2017-02-06 |
4 |
AS |
$43.15 |
$31,370 |
D/D |
(727) |
0 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2017-02-07 |
4 |
AS |
$44.61 |
$5,175 |
D/D |
(116) |
1,082 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2016-05-31 |
4 |
AS |
$50.00 |
$450,000 |
D/D |
(9,000) |
0 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2016-09-01 |
4 |
AS |
$50.00 |
$450,000 |
D/D |
(9,000) |
0 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2017-04-12 |
4 |
AS |
$50.41 |
$658,774 |
D/D |
(13,065) |
13,017 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
• – – |
2017-05-18 |
4 |
AS |
$53.26 |
$265,235 |
D/D |
(4,980) |
13,017 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
